Michael Floyd - Feb 9, 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Operating Officer
Signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Feb 9, 2023
Transactions value $
$8,000
Form type
4
Date filed
2/10/2023, 04:22 PM
Previous filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award $8K +10K +13.84% $0.80 82.3K Feb 9, 2023 Direct
holding PCSA Common Stock 89.8K Feb 9, 2023 by Elion Oncology, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.